Quantification of Retinal Ganglion Cell Morphology in Human Glaucomatous Eyes

Zhuolin Liu, Osamah Saeedi, Furu Zhang, Ricardo Villanueva, Samuel Asanad, Anant Agrawal, Daniel X Hammer, Zhuolin Liu, Osamah Saeedi, Furu Zhang, Ricardo Villanueva, Samuel Asanad, Anant Agrawal, Daniel X Hammer

Abstract

Purpose: To characterize retinal ganglion cell morphological changes in patients with primary open-angle glaucoma associated with hemifield defect (HD) using adaptive optics-optical coherence tomography (AO-OCT).

Methods: Six patients with early to moderate primary open-angle glaucoma with an average age of 58 years associated with HD and six age-matched healthy controls with an average age of 61 years were included. All participants underwent in vivo retinal ganglion cell (RGC) imaging at six primary locations across the macula with AO-OCT. Ganglion cell layer (GCL) somas were manually counted, and morphological parameters of GCL soma density, size, and symmetry were calculated. RGC cellular characteristics were correlated with functional visual field measurements.

Results: GCL soma density was 12,799 ± 7747 cells/mm2, 9370 ± 5572 cells/mm2, and 2134 ± 1494 cells/mm2 at 3°, 6°, and 12°, respectively, in glaucoma patients compared with 25,058 ± 4649 cells/mm2, 15,551 ± 2301 cells/mm2, and 3891 ± 1105 cells/mm2 (P < 0.05 for all locations) at the corresponding retinal locations in healthy participants. Mean soma diameter was significantly larger in glaucoma patients (14.20 ± 2.30 µm) compared with the health controls (12.32 ± 1.94 µm, P < 0.05 for all locations); symmetry was 0.36 ± 0.32 and 0.86 ± 0.13 in glaucoma and control cohorts, respectively.

Conclusions: Glaucoma patients had lower GCL soma density and symmetry, greater soma size, and increased variation of GCL soma reflectance compared with age-matched control subjects. The morphological changes corresponded with HD, and the cellular level structural loss correlated with visual function loss in glaucoma. AO-based morphological parameters could be potential sensitive biomarkers for glaucoma.

Conflict of interest statement

Disclosure: Z. Liu, adaptive optics–optical coherence tomography technology (P); O. Saeedi, Heidelberg Engineering (F); F. Zhang, adaptive optics–optical coherence tomography technology (P); R. Villanueva, None; S. Asanad, None; A. Agrawal, None; D.X. Hammer, None

Figures

Figure 1.
Figure 1.
Images of the right eye of a 54-year-old control subject (6289). Clinical data includes (A) fundus photograph, (B) Spectralis scanning laser ophthalmoscopy, and (C) optical coherence tomography B-scan at 2.5° superior retina, location denoted by blue arrow line in (B). There are no signs of glaucoma, such as disc-rim thinning or RNFL defects. The white rectangular box in (A) corresponds to the same region in (B) and the labeled seven white boxes in (B) are the locations where our adaptive optics–optical coherence tomography (AO-OCT) data were acquired. The white arrows in (C) corresponded with the three retinal locations (L1, L3, and L5) in (B). (D) Representative AO-OCT B-scans of the inner retina (from ILM to INL) on the left oriented vertically for comparison of hemifield differences and en face views of a single plane at the six corresponding retinal eccentricities (L1–L6). ILM, inner limiting membrane; RNFL, retinal nerve fiber layer; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer.
Figure 2.
Figure 2.
Images of the left eye of a 51-year-old glaucoma patient (1733) with superior hemifield defect. Clinical data include (A) optical coherence tomography (OCT) macula ganglion cell layer (GCL) thickness measurement, (B) hemisphere asymmetry map, (C) peripapillary retinal nerve fiber layer thickness classification, (D) 10-2, and (E) 24-2 VF PD maps, (F) Spectralis scanning laser ophthalmoscopy macula scan, and (G) OCT B-scan at 2.5° superior retina (denoted by blue arrow line in F). The light blue dots shown in the VF maps (D and E) correspond to the AO-OCT imaged locations at 3°, 6°, and 12°, respectively. OCT B-scan showed thinning of inner retina. The three white arrowheads associate with the three superior locations (L1, L3, and L5) in F. (H) AO-OCT B-scan and en face projection (single plane) at six retinal locations (L1–L6) showed a significant decrease in GCL soma density in the superior retina correlated with the HD. Representative three-dimensional volumetric visualization of 12°(L5) data set showed in Supplemental Video S2. B-scans at the paired locations were approximately aligned to the IPL for comparison. RNFL, retinal nerve fiber layer; optic nerve head (ONH), ILM, inner limiting membrane; RNFL, retinal nerve fiber layer; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer.
Figure 3.
Figure 3.
AO-OCT quantification of (A) ganglion cell layer (GCL) soma density, (B) Soma diameter, (C) Symmetry, and correlations between (D) Adaptive optics–optical coherence tomography (AO-OCT) measured GCL soma density and OCT (Spectralis) measured GCL thickness, (E) Adaptive optics–optical coherence tomography (AO-OCT) measured GCL soma density percentage and pattern deviation (PD), and (F) clinical OCT measured GCL thickness percentage and PD. A statistically significant difference was revealed between the glaucoma (purple) and control (green) groups in terms of GCL soma density, diameter and symmetry. Glaucoma caused cell morphology changes correlated with the hemifield defect. Open purple symbols () in (A) and (B) denote more diseased hemifield and filled purple symbols () represent relatively healthier hemifield. For the control group, open green symbols were from () superior retina and filled green symbols () are from inferior retina. In each plot, different symbols represent different subjects. In (D) data is color-coded with respect to eccentricity: 3° data in darkest color symbol and 12° in lightest color symbol. Colors in (E) and (F) are coded with respect to retinal eccentricities, and the percentage was normalized to control eyes. The black dashed line denotes x = −y that indicates an equal rate of structural and functional loss. While the true structure-function relationship is non-linear and more complex, a coarse rule-of-thumb is that datapoints above the x = −y line (log-log scaling) represent structural losses preceding functional loss and datapoints below represent the opposite. The red dashed line denotes 3 dB PD loss. P-Value < 0.01 **, and P-Value < 0.05 * (Students’ t-test). r in (D-E) is the Pearson correlation coefficient.
Figure 4.
Figure 4.
AO-OCT revealed subcellular reflectance changes in ganglion cell layer (GCL) somas in a 51-year-old early glaucoma patient (1733) at 12° (L5). (A) Representative AO-OCT en face image showed reflectance variations of three identified cells (arrows). (B–D) Magnified regions (65 µm × 65 µm) of the cells labeled in (A). (E) Magnified region of GCL somas from the same eccentricity of a 49-year-old healthy subject. (F) Radial profiles from the center of the cell reveal a distinctive pattern associated with subcellular hyporeflectivity in comparison to normal function in control subjects.
Figure 5.
Figure 5.
AO-OCT reveals hyperreflective structures in the defective hemifield (inferior retina) in the right eye of a 62-year-old glaucoma patient (1541, also see Supplemental Video S3 for the three-dimensional volumetric visualization of Adaptive optics–optical coherence tomography (AO-OCT) data taken at L2). Adaptive optics–optical coherence tomography (AO-OCT) B-scan and en face projections at six retinal locations (L1–L6) show a significant soma density reduction in the ganglion cell layer (GCL) (green) in the inferior retina correlated with the HD. hyperreflective structures were seen from en face projections of the inner plexiform layer (IPL) (purple) in two inferior retinal locations (L2 and L4). B-scans at the paired locations were approximately aligned to the IPL for comparison purpose. RNFL, retinal nerve fiber layer.
Figure 6.
Figure 6.
AO-OCT tracking of inner retinal changes at a 3° retinal location (L2) in the right eye of a 58-year-old patient (7365) with two visits. B-scan images taken: (A) first visit and (B) second visit. The Adaptive optics–optical coherence tomography (AO-OCT) volumes between the two visits were axially aligned to the top of IPL for comparison purpose. En face projection across 10 pixels (∼7 µm) of the ganglion cell layer (GCL) soma mosaic taken at (C) first visit and (D) second visit. (E) Magnified views of two labeled regions (blue boxes) from two visits. (F) Color merged en face projection across 20 pixels (∼14 µm) of IPL vessels between first (cyan) and second (magenta) visits demonstrated good registration and little vascular remodeling. Depth color maps showed superficial vessels in GCL in first visit (G) migrated posteriorly in the second visit in (H). The example branching vessel is labeled with white arrows. IPL, inner plexiform layer; NFL, nerve fiber layer.

References

    1. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121: 2081–2090.
    1. Nickells RW. From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can J Ophthalmol. 2007; 42: 278–287.
    1. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999; 18: 39–57.
    1. Saeedi OJ, Elze T, D'Acunto L, et al. .. Agreement and predictors of discordance of 6 visual field progression algorithms. Ophthalmology. 2019; 126: 822–828.
    1. Zhang X, Dastiridou A, Francis BA, et al. .. Comparison of glaucoma progression detection by optical coherence tomography and visual field. Am J Ophthalmol. 2017; 184: 63–74.
    1. Hood DC. Improving our understanding, and detection, of glaucomatous damage: An approach based upon optical coherence tomography (OCT). Prog Retin Eye Res. 2017; 57: 46–75.
    1. Medeiros FA, Zangwill LM, Bowd C, Mansouri K, Weinreb RN. The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change. Invest Ophthalmol Vis Sci. 2012; 53: 6939–6946.
    1. Adams CM, Stacy R, Rangaswamy N, Bigelow C, Grosskreutz CL, Prasanna G. Glaucoma—next generation therapeutics: impossible to possible. Pharm Res. 2018; 36(2): 25.
    1. Kuehn MH, Fingert JH, Kwon YH. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am. 2005; 18: 383–395.
    1. Liu Y, Pang IH. Challenges in the development of glaucoma neuroprotection therapy. Cell Tissue Res. 2013; 353: 253–260.
    1. Weber AJ, Kaufman PL, Hubbard WC. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Ophthalmol Vis Sci. 1998; 39: 2304–2320.
    1. Morgan JE. Retinal ganglion cell shrinkage in glaucoma. J Glaucoma. 2002; 11: 365–370.
    1. Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1991; 32: 584–491.
    1. Ahmed FA, Chaudhary P, Sharma SC. Effects of increased intraocular pressure on rat retinal ganglion cells. Int J Dev Neurosci. 2001; 19: 209–218.
    1. Kalesnykas G, Oglesby EN, Zack DJ, et al. .. Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma. Invest Ophthalmol Vis Sci. 2012; 53: 3847–3857.
    1. Pinar-Sueiro S, Urcola H, Rivas MA, Vecino E. Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model. Clin Exp Ophthalmol. 2011; 39: 799–807.
    1. Tribble JR, Vasalauskaite A, Redmond T, et al. Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma. Brain Commun. 2019; 1(1): fcz035.
    1. Hood DC. Does retinal ganglion cell loss precede visual field loss in glaucoma? J Glaucoma. 2019; 28: 945–951.
    1. Williams DR. Imaging single cells in the living retina. Vis Res. 2011; 51: 1379–1396.
    1. Jonnal RS, Kocaoglu OP, Zawadzki RJ, Liu Z, Miller DT, Werner JS. A review of adaptive optics optical coherence tomography: technical advances, scientific applications, and the future. Invest Ophthalmol Vis Sci. 2016; 57(9): OCT51–OCT68.
    1. Pircher M, Zawadzki RJ. Review of adaptive optics OCT (AO-OCT): principles and applications for retinal imaging [Invited]. Biomed Opt Express. 2017; 8: 2536–2562.
    1. Burns SA, Elsner AE, Sapoznik KA, Warner RL, Gast TJ. Adaptive optics imaging of the human retina. Prog Retin Eye Res. 2018; 68: 1–30.
    1. Miller DT, Kurokawa K. Cellular scale imaging of transparent retinal structures and processes using adaptive optics optical coherence tomography. Annu Rev Vis Sci. 2020; 6: 115–148.
    1. Nadler Z, Wang B, Wollstein G, et al. .. Repeatability of in vivo 3D lamina cribrosa microarchitecture using adaptive optics spectral domain optical coherence tomography. Biomed Opt Express. 2014; 5: 1114–1123.
    1. Akagi T, Hangai M, Takayama K, Nonaka A, Ooto S, Yoshimura N. In vivo imaging of lamina cribrosa pores by adaptive optics scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci. 2012; 53: 4111–4119.
    1. Hood DC, Lee D, Jarukasetphon R, et al. .. Progression of local glaucomatous damage near fixation as seen with adaptive optics imaging. Transl Vis Sci Technol. 2017; 6(4): 6.
    1. Takayama K, Ooto S, Hangai M, et al. .. High-resolution imaging of retinal nerve fiber bundles in glaucoma using adaptive optics scanning laser ophthalmoscopy. Am J Ophthalmol. 2013; 155: 870–881.
    1. Chen MF, Chui TY, Alhadeff P, et al. .. Adaptive optics imaging of healthy and abnormal regions of retinal nerve fiber bundles of patients with glaucoma. Invest Ophthalmol Vis Sci. 2015; 56: 674–681.
    1. Huang G, Luo T, Gast TJ, Burns SA, Malinovsky VE, Swanson WH. Imaging glaucomatous damage across the temporal raphe. Invest Ophthalmol Vis Sci. 2015; 56: 3496–3504.
    1. Swanson WH, King BJ, Burns SA. Within-subject variability in human retinal nerve fiber bundle width. PLoS One. 2019; 14: e0223350.
    1. Scoles D, Gray DC, Hunter JJ, et al. .. In-vivo imaging of retinal nerve fiber layer vasculature: imaging histology comparison. BMC Ophthalmol. 2009; 9: 9.
    1. Wells-Gray EM, Choi SS, Slabaugh M, Weber P, Doble N. Inner retinal changes in primary open-angle glaucoma revealed through adaptive optics-optical coherence tomography. J Glaucoma. 2018; 27: 1025–1028.
    1. Hasegawa T, Ooto S, Takayama K, et al. .. Cone integrity in glaucoma: an adaptive-optics scanning laser ophthalmoscopy study. Am J Ophthalmol. 2016; 171: 53–66.
    1. Choi SS, Zawadzki RJ, Lim MC, et al. .. Evidence of outer retinal changes in glaucoma patients as revealed by ultrahigh-resolution in vivo retinal imaging. Br J Ophthalmol. 2011; 95: 131–141.
    1. Rossi EA, Granger CE, Sharma R, et al. .. Imaging individual neurons in the retinal ganglion cell layer of the living eye. Proc Natl Acad Sci USA. 2017; 114: 586–591.
    1. Liu Z, Kurokawa K, Zhang F, Lee JJ, Miller DT. Imaging and quantifying ganglion cells and other transparent neurons in the living human retina. Proc Natl Acad Sci USA. 2017; 114: 12803–12808.
    1. Sharma R, Williams DR, Palczewska G, Palczewski K, Hunter JJ. Two-photon autofluorescence imaging reveals cellular structures throughout the retina of the living primate eye. Invest Ophthalmol Vis Sci. 2016; 57: 632–646.
    1. Prum BEJr., Lim MC, Mansberger SL, et al. .. Primary open-angle glaucoma suspect preferred practice pattern guidelines. Ophthalmology. 2016; 123: P112–P151.
    1. Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St. Louis: Mosby–YearBook; 1993: 52–61.
    1. Liu Z, Tam J, Saeedi O, Hammer DX. Trans-retinal cellular imaging with multimodal adaptive optics. Biomed Opt Express. 2018; 9(9): 4246–4262.
    1. ANSI, Z136.1 –2014. American National Standard for Safe Use of Lasers. Orlando: Laser Institute of America; 2014.
    1. Do NH. Parallel processing for adaptive optics optical coherence tomography (AO-OCT) image registration using GPU [master's thesis]. (Indianapolis: Indiana University–Purdue University Indianapolis; 2016.
    1. Bennett AG, Rudnicka AR, Edgar DF. Improvements on Littmann's method of determining the size of retinal features by fundus photography. Graefes Arch Clin Exp Ophthalmol. 1994; 232(6): 361–367.
    1. Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990; 300: 5–25.
    1. Heijl A, Patella V, Bengtsson B. The Field Analyzer Primer: Effective Perimetry. 4th Ed. Dublin, CA: Carl Zeiss Meditec; 2012.
    1. Pazos M, Dyrda AA, Biarnes M, Gomez A, Martin C, Mora C, Fatti G, Anton A. Diagnostic Accuracy of Spectralis SD OCT Automated Macular Layers Segmentation to Discriminate Normal from Early Glaucomatous Eyes. Ophthalmology. 2017; 124: 1218–1228.
    1. Watson AB. A formula for human retinal ganglion cell receptive field density as a function of visual field location. J Vis. 2014; 14(7): 15.
    1. Stone J, Johnston E. The topography of primate retina: a study of the human, bushbaby, and new- and old-world monkeys. J Comp Neurol. 1981; 196: 205–223.
    1. Blanks JC, Torigoe Y, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging. 1996; 17: 377–384.
    1. Rodieck RW, Binmoeller KF, Dineen J. Parasol and midget ganglion cells of the human retina. J Comp Neurol. 1985; 233: 115–132.
    1. Pavlidis M, Stupp T, Hummeke M, Thanos S. Morphometric examination of human and monkey retinal ganglion cells within the papillomacular area. Retina. 2006; 26: 445–453.
    1. McKendrick AM, Badcock DR, Morgan WH. Psychophysical measurement of neural adaptation abnormalities in magnocellular and parvocellular pathways in glaucoma. Invest Ophthalmol Vis Sci. 2004; 45: 1846–1853.
    1. Soltanian-Zadeh S, Kurokawa K, Liu Z, Hammer DX, Miller DT, Farsiu S. Fully automatic quantification of individual ganglion cells from AO-OCT volumes via weakly supervised learning. Ophthalmic Technologies XXX. 2020; 11218: 112180Q.
    1. Drasdo N, Millican CL, Katholi CR, Curcio CA. The length of Henle fibers in the human retina and a model of ganglion receptive field density in the visual field. Vis Res. 2007; 47: 2901–2911.
    1. Bensinger E, Rinella N, Saud A, et al. .. Loss of foveal cone structure precedes loss of visual acuity in patients with rod-cone degeneration. Invest Ophthalmol Vis Sci. 2019; 60(8): 3187–3196.
    1. Gardiner SK, Mansberger SL, Fortune B. Time lag between functional change and loss of retinal nerve fiber layer in glaucoma. Invest Ophthalmol Vis Sci. 2020; 61(13): 5–5.
    1. Hammer DX, Liu Z, Cava JA, Carroll J, Saeedi O. On the axial location of Gunn's dots. Am J Ophthalmol Case Rep. 2020; 19: 100757.
    1. Hammer DX, Villanueva R, Agrawal A, Saeedi O, Liu Z. Distribution of inner limiting membrane microglia in glaucoma measured with adaptive optics–optical coherence tomography. Invest Ophthalmol Vis Sci. 2020; 61(7): 3498.
    1. Kurokawa K, Crowell JA, Zhang F, Miller DT. Suite of methods for assessing inner retinal temporal dynamics across spatial and temporal scales in the living human eye. Neurophotonics. 2020; 7(1): 015013.
    1. Alberts B, Johnson A, Lewis J, Morgan D, Raff M, Roberts K. Molecular Biology of the Cell. 6th ed. New York: W. W. Norton & Company; 2014.
    1. Cordeiro MF, Normando EM, Cardoso MJ, et al. .. Real-time imaging of single neuronal cell apoptosis in patients with glaucoma. Brain. 2017; 140: 1757–1767.
    1. Dubin MW. The inner plexiform layer of the vertebrate retina: a quantitative and comparative electron microscopic analysis. J Comp Neurol. 1970; 140: 479–505.
    1. Rathnasamy G, Foulds WS, Ling EA, Kaur C. Retinal microglia—A key player in healthy and diseased retina. Prog Neurobiol. 2019; 173: 18–40.
    1. Distler C, Dreher Z. Glia cells of the monkey retina–II. Muller cells. Vis Res. 1996; 36(16): 2381–2394.
    1. Franze K, Grosche J, Skatchkov SN, Schinkinger S, Foja C, Schild D, Uckermann O, Travis K, Reichenbach A, Guck J. Muller cells are living optical fibers in the vertebrate retina. Proc Natl Acad Sci USA. 2007; 104(20): 8287–8292.
    1. Shou T, Liu J, Wang W, Zhou Y, Zhao K. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci. 2003; 44: 3005–3010.
    1. Feng L, Zhao Y, Yoshida M, et al. .. Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location. Invest Ophthalmol Vis Sci. 2013; 54(2): 1106–1117.
    1. El-Danaf RN, Huberman AD. Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types. J Neurosci. 2015; 35: 2329–2343.
    1. Risner ML, Pasini S, Cooper ML, Lambert WS, Calkins DJ. Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma. Proc Natl Acad Sci USA. 2018; 115: E2393–E2402.
    1. Perez De Sevilla Muller L, Shelley J, Weiler R. Displaced amacrine cells of the mouse retina. J Comp Neurol. 2007; 505: 177–189.
    1. Balendra SI, Normando EM, Bloom PA, Cordeiro MF. Advances in retinal ganglion cell imaging. Eye (Lond). 2015; 29: 1260–1269.
    1. Hammer DX, Agrawal A, Villanueva R, Saeedi O, Liu Z. Label-free adaptive optics imaging of human retinal macrophage distribution and dynamics. Proc Natl Acad Sci USA. 2020; 117: 30661–30669.
    1. Silverman SM, Wong WT. Microglia in the retina: roles in development, maturity, and disease. Ann Rev Vis Sci. 2018; 4: 45–77.
    1. Kocaoglu OP, Turner TL, Liu Z, Miller DT. Adaptive optics optical coherence tomography at 1 MHz. Biomed Opt Express. 2014; 5: 4186–4200.

Source: PubMed

3
Abonneren